首页> 外文OA文献 >A mathematical model to identify optimal combinations of drug targets for dupilumab poor responders in atopic dermatitis

【2h】

A mathematical model to identify optimal combinations of drug targets for dupilumab poor responders in atopic dermatitis

机译：一种数学模型，以确定特应性皮炎杜帕米布患者药物靶标的最佳组合

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Takuya Miyano; Alan D. Irvine; Reiko J. Tanaka;
展开▼
作者单位

展开▼
年度 2021
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Filaggrin in atopic dermatitis: flaky tail mice as a novel model for developing drug targets in atopic dermatitis. [J] . Moniaga CS, Kabashima K Inflammation & allergy drug targets. . 2011,第6期

机译：异位性皮炎中的丝聚蛋白：片状尾巴小鼠是在异位性皮炎中发展药物靶标的新型模型。
2. Management Recommendations for Dupilumab Partial and Non-durable Responders in Atopic Dermatitis [J] . Hendricks Aleksi J., Lio Peter A., Shi Vivian Y. American journal of clinical dermatology . 2019,第4期

机译：针对特应性皮炎的Dupilumab部分和非持久响应者的管理建议
3. Evaluation of Potential Disease-Mediated Drug-Drug Interaction in Patients With Moderate-to-Severe Atopic Dermatitis Receiving Dupilumab [J] . Davis John D., Bansal Ashish, Hassman David, Clinical Pharmacology and Therapeutics . 2018,第6期

机译：评估患者中度至严重的特征性皮炎接受杜帕里米亚患者患者的潜在疾病介导的药物 - 药物相互作用
4. Study on the application of magnetic nanoparticles as drug delivery particles on the atopic dermatitis [C] . Gang An, Ping Ma, Dongying JU, International forum on advanced materials science and technology . 2013

机译：磁性纳米粒子在药物递送颗粒对特应性皮炎的应用研究
5. Lonicerae Formula and Its Extracts as a Potential Intervention in Atopic Dermatitis for a Clinical Case, Animal Model, and Molecular Targets of Inflammation [D] . Uzun, Serife Elif. 2018

机译：金银花配方及其提取物作为特应性皮炎的一种潜在干预手段，用于临床病例，动物模型和炎症分子靶标
6. Evaluation of Potential Disease‐Mediated Drug–Drug Interaction in Patients With Moderate‐to‐Severe Atopic Dermatitis Receiving Dupilumab [O] . John D. Davis, Ashish Bansal, David Hassman, -1

机译：中度至重度特应性皮炎患者接受Dupilumab的潜在疾病介导的药物相互作用的评估
7. Evaluation of Potential Disease-Mediated Drug-Drug Interaction in Patients With Moderate-to-Severe Atopic Dermatitis Receiving Dupilumab [O] . John D. Davis, Ashish Bansal, David Hassman, 2018

机译：评估患者中度至严重的特征性皮炎接受杜帕里米亚患者患者的潜在疾病介导的药物 - 药物相互作用

A mathematical model to identify optimal combinations of drug targets for dupilumab poor responders in atopic dermatitis

著录项

引文网络

相似文献

相关主题

期刊订阅